Literature DB >> 30972450

Mechanisms and in vitro models of drug-induced cholestasis.

Eva Gijbels1, Vânia Vilas-Boas1, Neel Deferm2, Lindsey Devisscher3, Hartmut Jaeschke4, Pieter Annaert2, Mathieu Vinken5.   

Abstract

Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of factors that induce 2 types of biological responses, namely a deteriorative response, caused by bile acid accumulation, and an adaptive response, aimed at removing the accumulated bile acids. Several key events in both types of responses have been characterized in the past few years. In parallel, many efforts have focused on the development and further optimization of experimental cell culture models to predict the occurrence of drug-induced cholestatic liver toxicity in vivo. In this paper, a state-of-the-art overview of mechanisms and in vitro models of drug-induced cholestatic liver injury is provided.

Entities:  

Keywords:  Drug-induced cholestasis; In vitro models; Liver; Mechanisms

Mesh:

Substances:

Year:  2019        PMID: 30972450     DOI: 10.1007/s00204-019-02437-2

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  9 in total

1.  Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.

Authors:  Vânia Vilas-Boas; Eva Gijbels; Axelle Cooreman; Raf Van Campenhout; Emma Gustafson; Kaat Leroy; Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2019-06-18       Impact factor: 3.739

2.  Cholestasis Differentially Affects Liver Connexins.

Authors:  Axelle Cooreman; Raf Van Campenhout; Sara Crespo Yanguas; Eva Gijbels; Kaat Leroy; Alanah Pieters; Andrés Tabernilla; Pieter Van Brantegem; Pieter Annaert; Bruno Cogliati; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 3.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

4.  Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals.

Authors:  Vânia Vilas-Boas; Eva Gijbels; Kaat Leroy; Alanah Pieters; Audrey Baze; Céline Parmentier; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 6.208

5.  Norethisterone-induced cholestasis: A case report.

Authors:  Safa Moussaoui; Mehdi Abdelwahed; Nabil Ben Chaaben; Ahlem Bellalah; Najah Ben Fadhel; Arwa Guediche; Mejda Zakhama; Ramzi Tababi; Karim Aouam; Zakhama Abdelfattah; Hichem Loghmari; Leila Safer
Journal:  Clin Case Rep       Date:  2022-03-03

6.  Kuhuang injection exerts a protective effect by activating PPAR-γ in an in vitro model of chlorpromazine-induced cholestatic liver injury constructed by tissue engineering.

Authors:  Qiao Wu; Zhongping Duan; Long Huang; Zhijie Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 7.  PPARα: A potential therapeutic target of cholestasis.

Authors:  Xiaoyin Ye; Tong Zhang; Han Han
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

8.  Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury.

Authors:  Lindsey Devisscher; Mathieu Vinken; Eva Gijbels; Vânia Vilas-Boas; Pieter Annaert; Tamara Vanhaecke
Journal:  Arch Toxicol       Date:  2020-03-10       Impact factor: 5.153

Review 9.  In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach.

Authors:  Andrés Tabernilla; Bruna Dos Santos Rodrigues; Alanah Pieters; Anne Caufriez; Kaat Leroy; Raf Van Campenhout; Axelle Cooreman; Ana Rita Gomes; Emma Arnesdotter; Eva Gijbels; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.